The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gayer Charles K since 2024.
This trader's CIK number is 1800110.
At the time of last reporting, Gayer Charles K was the President and CCO of Biocryst Pharmaceuticals Inc. (stock ticker symbol BCRX).
Also see all insider trading activities at Biocryst Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BCRX | 0 | $0 | 0 | $0 | 74,233 | $340,729 |
| 2024 | BCRX | 30,000 | $164,100 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-22 | BCRX | Option Ex | 74,233 | 4.59 | 340,729 |
| 2024-05-13 | BCRX | Buy | 30,000 | 5.47 | 164,100 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gayer Charles K (President and CCO of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.